ISMH Men's Health Academy

Dear colleagues,

We are very pleased about your interest in the ISMH Men's Health Academy.

Why do we offer this educational tool? What is our intention?

With this new approach to education the ISMH is again on the forefront of men's health education and adapts to the changes in education, health care and economy. The ISMH Men's Health Academy intends to serve men's health with special balance of global and local needs as well as academic and practical needs.

The following presentation will focus on hypogonadism, a highly prevalent and widely under-diagnosed condition with far-reaching health and social consequences. Hypogonadism or testosterone deficiency is increasingly recognized as more than a marker for sexual function. Testosterone is now understood to be an integral component of many metabolic pathways associated with obesity, type-2-diabetes-mellitus and cardiometabolic risk profile.

After a brief review of the epidemiology and burden of disease, our focus will turn to recent important clinical data in Testosterone replacement therapy. Practical recommendations will aim to help make sense of the wide range of guidelines available.

We do hope that you learn some more facts about hypogonadism and men's health.

Yours sincerely

Prof. Siegfried Meryn

General Secretary, International Society of Men's Health

Chairman's welcome and introduction (5,24 min)

*Video:introduction

Speaker: Ridwan Shabsigh, MD, FACS

President ISMH
Director, Division of Urology, Maimonides Medical Center
Professor of Clinical Urology, Columbia University
(New York, USA)

Download slides




The epidemiology and burden of hypogonadism (21,33 min)

*Video:introduction

Speaker: Siegfried Meryn, MD

General Secretary ISMH
Professor of Medicine, Medical University of Vienna
(Vienna, Austria)

Download slides




The clinical picture of hypogonadism (22,58 min)

*Video:introduction

Speaker: Miles Spar, MD, MPH

Director, Men's Clinic and Medical Director, Akasha Center for Integrative Medicine
Clinical Instructor at the UCLA David Geffen School of Medicine
(Los Angeles, USA)

Download slides




To screen or not to screen? (8,17 min)

*Video:introduction

Speaker: Siegfried Meryn, MD

General Secretary ISMH
Professor of Medicine, Medical University of Vienna
(Vienna, Austria)

Download slides




The role of TRT in the management of hypogonadism (34,53 min)

*Video:introduction

Speaker: Geoffrey Hackett, MD

Consultant Urologist Good Hope Hospital
(Sutton Coldfield Birmingham, United Kingdom)

Download slides



The evidence for TRT (35 min)

*Video:introduction

Speaker: Ridwan Shabsigh, MD, FACS

President ISMH
Director, Division of Urology, Maimonides Medical Center
Professor of Clinical Urology, Columbia University
(New York, USA)





Who do I treat when, how and with what – making sense of the guidelines (25,18 min)

*Video:introduction

Speaker: Joel J. Heidelbaugh, MD, FAAFP

Associate Professor (Clinical Track)
Departments of Family Medicine and Urology, Ypsilanti Health Center
(Michigan, USA)